Moleculin Biotech (NASDAQ:MBRX) Now Covered by Analysts at StockNews.com
StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research note released on Tuesday morning. The brokerage issued a sell rating on the stock. Separately, Maxim Group cut shares of Moleculin Biotech from a “buy” rating to a “hold” rating in a report on Wednesday, February 12th. Get Our Latest […]
StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research note released on Tuesday morning. The brokerage issued a sell rating on the stock. Separately, Maxim Group cut shares of Moleculin Biotech from a “buy” rating to a “hold” rating in a report on Wednesday, February 12th. Get Our Latest […]
